Xiaoqiang Kang

2PUBLICATIONS
22CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 11, 2025
Anti-LAG-3 Antibody LBL-007 plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial.

Dongchen Sun, Gang Chen, Yu Chen

|Jun 27, 2019
Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapy.

Xiaojie Yu, Xiao Huang, Xiuxiu Chen

Pageof 1

Frequent Collaborators

1 joint publications

Dongchen Sun

1 joint publications

Gang Chen

1 joint publications

Yu Chen

1 joint publications

Song Qu